aluates Reports

$ 0.0

Automative

Global COVID-19 Medicine Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-17R2563

Global COVID 19 Medicine Market Size Status and Forecast 2022 2028

BUY CHAPTERS

Global COVID-19 Medicine Market Research Report 2024

Code: QYRE-Auto-17R2563

Report

March 2024

Pages:97

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Advanz Pharma

Kyung Poong

Mylan NV

Novartis

Sanofi

Apotex

Bayer

Guangzhou Baiyunshan Guanghua Pharmaceutical

Ipca Laboratories

Sichuan Sunny Hope

Zydus Cadila

TEVA

Sun Pharma

Rising Pharmaceutical

KPC Group

Bristol Laboratories

Shanghai Zhongxisanwei

Shanghai Pharma

COVID-19 Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

COVID-19 Medicine Market

The global COVID-19 Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for COVID-19 Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Medicine.

Report Scope

The COVID-19 Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COVID-19 Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the COVID-19 Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of COVID-19 Medicine Market Report

Report Metric	Details
Report Name	COVID-19 Medicine Market
CAGR	5%
Segment by Type	Tablet Injection
Segment by Application	Patients With Mild Symptoms Critically Ill Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Advanz Pharma, Kyung Poong, Mylan, Novartis, Sanofi, Apotex, Bayer, Guangzhou Baiyunshan Guanghua Pharmaceutical, Ipca Laboratories, Sichuan Sunny Hope, Zydus Cadila, Teva, Sun Pharma, Rising Pharmaceutical, KPC Group, Bristol Laboratories, Shanghai Zhongxisanwei, Shanghai Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COVID-19 Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the COVID-19 Medicine Market report?

Ans: The main players in the COVID-19 Medicine Market are Advanz Pharma, Kyung Poong, Mylan, Novartis, Sanofi, Apotex, Bayer, Guangzhou Baiyunshan Guanghua Pharmaceutical, Ipca Laboratories, Sichuan Sunny Hope, Zydus Cadila, Teva, Sun Pharma, Rising Pharmaceutical, KPC Group, Bristol Laboratories, Shanghai Zhongxisanwei, Shanghai Pharma

What are the Application segmentation covered in the COVID-19 Medicine Market report?

Ans: The Applications covered in the COVID-19 Medicine Market report are Patients With Mild Symptoms, Critically Ill, Other

What are the Type segmentation covered in the COVID-19 Medicine Market report?

Ans: The Types covered in the COVID-19 Medicine Market report are Tablet, Injection

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global COVID-19 Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Tablet

1.2.3 Injection

1.3 Market by Application

1.3.1 Global COVID-19 Medicine Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Patients With Mild Symptoms

1.3.3 Critically Ill

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global COVID-19 Medicine Market Perspective (2019-2030)

2.2 COVID-19 Medicine Growth Trends by Region

2.2.1 Global COVID-19 Medicine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 COVID-19 Medicine Historic Market Size by Region (2019-2024)

2.2.3 COVID-19 Medicine Forecasted Market Size by Region (2025-2030)

2.3 COVID-19 Medicine Market Dynamics

2.3.1 COVID-19 Medicine Industry Trends

2.3.2 COVID-19 Medicine Market Drivers

2.3.3 COVID-19 Medicine Market Challenges

2.3.4 COVID-19 Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top COVID-19 Medicine Players by Revenue

3.1.1 Global Top COVID-19 Medicine Players by Revenue (2019-2024)

3.1.2 Global COVID-19 Medicine Revenue Market Share by Players (2019-2024)

3.2 Global COVID-19 Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by COVID-19 Medicine Revenue

3.4 Global COVID-19 Medicine Market Concentration Ratio

3.4.1 Global COVID-19 Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Medicine Revenue in 2023

3.5 COVID-19 Medicine Key Players Head office and Area Served

3.6 Key Players COVID-19 Medicine Product Solution and Service

3.7 Date of Enter into COVID-19 Medicine Market

3.8 Mergers & Acquisitions, Expansion Plans

4 COVID-19 Medicine Breakdown Data by Type

4.1 Global COVID-19 Medicine Historic Market Size by Type (2019-2024)

4.2 Global COVID-19 Medicine Forecasted Market Size by Type (2025-2030)

5 COVID-19 Medicine Breakdown Data by Application

5.1 Global COVID-19 Medicine Historic Market Size by Application (2019-2024)

5.2 Global COVID-19 Medicine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America COVID-19 Medicine Market Size (2019-2030)

6.2 North America COVID-19 Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America COVID-19 Medicine Market Size by Country (2019-2024)

6.4 North America COVID-19 Medicine Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe COVID-19 Medicine Market Size (2019-2030)

7.2 Europe COVID-19 Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe COVID-19 Medicine Market Size by Country (2019-2024)

7.4 Europe COVID-19 Medicine Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific COVID-19 Medicine Market Size (2019-2030)

8.2 Asia-Pacific COVID-19 Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific COVID-19 Medicine Market Size by Region (2019-2024)

8.4 Asia-Pacific COVID-19 Medicine Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America COVID-19 Medicine Market Size (2019-2030)

9.2 Latin America COVID-19 Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America COVID-19 Medicine Market Size by Country (2019-2024)

9.4 Latin America COVID-19 Medicine Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa COVID-19 Medicine Market Size (2019-2030)

10.2 Middle East & Africa COVID-19 Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa COVID-19 Medicine Market Size by Country (2019-2024)

10.4 Middle East & Africa COVID-19 Medicine Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Advanz Pharma

11.1.1 Advanz Pharma Company Detail

11.1.2 Advanz Pharma Business Overview

11.1.3 Advanz Pharma COVID-19 Medicine Introduction

11.1.4 Advanz Pharma Revenue in COVID-19 Medicine Business (2019-2024)

11.1.5 Advanz Pharma Recent Development

11.2 Kyung Poong

11.2.1 Kyung Poong Company Detail

11.2.2 Kyung Poong Business Overview

11.2.3 Kyung Poong COVID-19 Medicine Introduction

11.2.4 Kyung Poong Revenue in COVID-19 Medicine Business (2019-2024)

11.2.5 Kyung Poong Recent Development

11.3 Mylan

11.3.1 Mylan Company Detail

11.3.2 Mylan Business Overview

11.3.3 Mylan COVID-19 Medicine Introduction

11.3.4 Mylan Revenue in COVID-19 Medicine Business (2019-2024)

11.3.5 Mylan Recent Development

11.4 Novartis

11.4.1 Novartis Company Detail

11.4.2 Novartis Business Overview

11.4.3 Novartis COVID-19 Medicine Introduction

11.4.4 Novartis Revenue in COVID-19 Medicine Business (2019-2024)

11.4.5 Novartis Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi COVID-19 Medicine Introduction

11.5.4 Sanofi Revenue in COVID-19 Medicine Business (2019-2024)

11.5.5 Sanofi Recent Development

11.6 Apotex

11.6.1 Apotex Company Detail

11.6.2 Apotex Business Overview

11.6.3 Apotex COVID-19 Medicine Introduction

11.6.4 Apotex Revenue in COVID-19 Medicine Business (2019-2024)

11.6.5 Apotex Recent Development

11.7 Bayer

11.7.1 Bayer Company Detail

11.7.2 Bayer Business Overview

11.7.3 Bayer COVID-19 Medicine Introduction

11.7.4 Bayer Revenue in COVID-19 Medicine Business (2019-2024)

11.7.5 Bayer Recent Development

11.8 Guangzhou Baiyunshan Guanghua Pharmaceutical

11.8.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Detail

11.8.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview

11.8.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Introduction

11.8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Medicine Business (2019-2024)

11.8.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development

11.9 Ipca Laboratories

11.9.1 Ipca Laboratories Company Detail

11.9.2 Ipca Laboratories Business Overview

11.9.3 Ipca Laboratories COVID-19 Medicine Introduction

11.9.4 Ipca Laboratories Revenue in COVID-19 Medicine Business (2019-2024)

11.9.5 Ipca Laboratories Recent Development

11.10 Sichuan Sunny Hope

11.10.1 Sichuan Sunny Hope Company Detail

11.10.2 Sichuan Sunny Hope Business Overview

11.10.3 Sichuan Sunny Hope COVID-19 Medicine Introduction

11.10.4 Sichuan Sunny Hope Revenue in COVID-19 Medicine Business (2019-2024)

11.10.5 Sichuan Sunny Hope Recent Development

11.11 Zydus Cadila

11.11.1 Zydus Cadila Company Detail

11.11.2 Zydus Cadila Business Overview

11.11.3 Zydus Cadila COVID-19 Medicine Introduction

11.11.4 Zydus Cadila Revenue in COVID-19 Medicine Business (2019-2024)

11.11.5 Zydus Cadila Recent Development

11.12 Teva

11.12.1 Teva Company Detail

11.12.2 Teva Business Overview

11.12.3 Teva COVID-19 Medicine Introduction

11.12.4 Teva Revenue in COVID-19 Medicine Business (2019-2024)

11.12.5 Teva Recent Development

11.13 Sun Pharma

11.13.1 Sun Pharma Company Detail

11.13.2 Sun Pharma Business Overview

11.13.3 Sun Pharma COVID-19 Medicine Introduction

11.13.4 Sun Pharma Revenue in COVID-19 Medicine Business (2019-2024)

11.13.5 Sun Pharma Recent Development

11.14 Rising Pharmaceutical

11.14.1 Rising Pharmaceutical Company Detail

11.14.2 Rising Pharmaceutical Business Overview

11.14.3 Rising Pharmaceutical COVID-19 Medicine Introduction

11.14.4 Rising Pharmaceutical Revenue in COVID-19 Medicine Business (2019-2024)

11.14.5 Rising Pharmaceutical Recent Development

11.15 KPC Group

11.15.1 KPC Group Company Detail

11.15.2 KPC Group Business Overview

11.15.3 KPC Group COVID-19 Medicine Introduction

11.15.4 KPC Group Revenue in COVID-19 Medicine Business (2019-2024)

11.15.5 KPC Group Recent Development

11.16 Bristol Laboratories

11.16.1 Bristol Laboratories Company Detail

11.16.2 Bristol Laboratories Business Overview

11.16.3 Bristol Laboratories COVID-19 Medicine Introduction

11.16.4 Bristol Laboratories Revenue in COVID-19 Medicine Business (2019-2024)

11.16.5 Bristol Laboratories Recent Development

11.17 Shanghai Zhongxisanwei

11.17.1 Shanghai Zhongxisanwei Company Detail

11.17.2 Shanghai Zhongxisanwei Business Overview

11.17.3 Shanghai Zhongxisanwei COVID-19 Medicine Introduction

11.17.4 Shanghai Zhongxisanwei Revenue in COVID-19 Medicine Business (2019-2024)

11.17.5 Shanghai Zhongxisanwei Recent Development

11.18 Shanghai Pharma

11.18.1 Shanghai Pharma Company Detail

11.18.2 Shanghai Pharma Business Overview

11.18.3 Shanghai Pharma COVID-19 Medicine Introduction

11.18.4 Shanghai Pharma Revenue in COVID-19 Medicine Business (2019-2024)

11.18.5 Shanghai Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Advanz Pharma

Kyung Poong

Mylan NV

Novartis

Sanofi

Apotex

Bayer

Guangzhou Baiyunshan Guanghua Pharmaceutical

Ipca Laboratories

Sichuan Sunny Hope

Zydus Cadila

TEVA

Sun Pharma

Rising Pharmaceutical

KPC Group

Bristol Laboratories

Shanghai Zhongxisanwei

Shanghai Pharma

List of Tables

Table 1. Global COVID-19 Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Tablet

Table 3. Key Players of Injection

Table 4. Global COVID-19 Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global COVID-19 Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global COVID-19 Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global COVID-19 Medicine Market Share by Region (2019-2024)

Table 8. Global COVID-19 Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global COVID-19 Medicine Market Share by Region (2025-2030)

Table 10. COVID-19 Medicine Market Trends

Table 11. COVID-19 Medicine Market Drivers

Table 12. COVID-19 Medicine Market Challenges

Table 13. COVID-19 Medicine Market Restraints

Table 14. Global COVID-19 Medicine Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global COVID-19 Medicine Market Share by Players (2019-2024)

Table 16. Global Top COVID-19 Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Medicine as of 2023)

Table 17. Ranking of Global Top COVID-19 Medicine Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by COVID-19 Medicine Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players COVID-19 Medicine Product Solution and Service

Table 21. Date of Enter into COVID-19 Medicine Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global COVID-19 Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global COVID-19 Medicine Revenue Market Share by Type (2019-2024)

Table 25. Global COVID-19 Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global COVID-19 Medicine Revenue Market Share by Type (2025-2030)

Table 27. Global COVID-19 Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global COVID-19 Medicine Revenue Market Share by Application (2019-2024)

Table 29. Global COVID-19 Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global COVID-19 Medicine Revenue Market Share by Application (2025-2030)

Table 31. North America COVID-19 Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America COVID-19 Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America COVID-19 Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe COVID-19 Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe COVID-19 Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe COVID-19 Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific COVID-19 Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific COVID-19 Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific COVID-19 Medicine Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America COVID-19 Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America COVID-19 Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America COVID-19 Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa COVID-19 Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa COVID-19 Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa COVID-19 Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 46. Advanz Pharma Company Detail

Table 47. Advanz Pharma Business Overview

Table 48. Advanz Pharma COVID-19 Medicine Product

Table 49. Advanz Pharma Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 50. Advanz Pharma Recent Development

Table 51. Kyung Poong Company Detail

Table 52. Kyung Poong Business Overview

Table 53. Kyung Poong COVID-19 Medicine Product

Table 54. Kyung Poong Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 55. Kyung Poong Recent Development

Table 56. Mylan Company Detail

Table 57. Mylan Business Overview

Table 58. Mylan COVID-19 Medicine Product

Table 59. Mylan Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 60. Mylan Recent Development

Table 61. Novartis Company Detail

Table 62. Novartis Business Overview

Table 63. Novartis COVID-19 Medicine Product

Table 64. Novartis Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 65. Novartis Recent Development

Table 66. Sanofi Company Detail

Table 67. Sanofi Business Overview

Table 68. Sanofi COVID-19 Medicine Product

Table 69. Sanofi Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 70. Sanofi Recent Development

Table 71. Apotex Company Detail

Table 72. Apotex Business Overview

Table 73. Apotex COVID-19 Medicine Product

Table 74. Apotex Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 75. Apotex Recent Development

Table 76. Bayer Company Detail

Table 77. Bayer Business Overview

Table 78. Bayer COVID-19 Medicine Product

Table 79. Bayer Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 80. Bayer Recent Development

Table 81. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Detail

Table 82. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview

Table 83. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product

Table 84. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 85. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development

Table 86. Ipca Laboratories Company Detail

Table 87. Ipca Laboratories Business Overview

Table 88. Ipca Laboratories COVID-19 Medicine Product

Table 89. Ipca Laboratories Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 90. Ipca Laboratories Recent Development

Table 91. Sichuan Sunny Hope Company Detail

Table 92. Sichuan Sunny Hope Business Overview

Table 93. Sichuan Sunny Hope COVID-19 Medicine Product

Table 94. Sichuan Sunny Hope Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 95. Sichuan Sunny Hope Recent Development

Table 96. Zydus Cadila Company Detail

Table 97. Zydus Cadila Business Overview

Table 98. Zydus Cadila COVID-19 Medicine Product

Table 99. Zydus Cadila Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 100. Zydus Cadila Recent Development

Table 101. Teva Company Detail

Table 102. Teva Business Overview

Table 103. Teva COVID-19 Medicine Product

Table 104. Teva Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 105. Teva Recent Development

Table 106. Sun Pharma Company Detail

Table 107. Sun Pharma Business Overview

Table 108. Sun Pharma COVID-19 Medicine Product

Table 109. Sun Pharma Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 110. Sun Pharma Recent Development

Table 111. Rising Pharmaceutical Company Detail

Table 112. Rising Pharmaceutical Business Overview

Table 113. Rising Pharmaceutical COVID-19 Medicine Product

Table 114. Rising Pharmaceutical Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 115. Rising Pharmaceutical Recent Development

Table 116. KPC Group Company Detail

Table 117. KPC Group Business Overview

Table 118. KPC Group COVID-19 Medicine Product

Table 119. KPC Group Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 120. KPC Group Recent Development

Table 121. Bristol Laboratories Company Detail

Table 122. Bristol Laboratories Business Overview

Table 123. Bristol Laboratories COVID-19 Medicine Product

Table 124. Bristol Laboratories Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 125. Bristol Laboratories Recent Development

Table 126. Shanghai Zhongxisanwei Company Detail

Table 127. Shanghai Zhongxisanwei Business Overview

Table 128. Shanghai Zhongxisanwei COVID-19 Medicine Product

Table 129. Shanghai Zhongxisanwei Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 130. Shanghai Zhongxisanwei Recent Development

Table 131. Shanghai Pharma Company Detail

Table 132. Shanghai Pharma Business Overview

Table 133. Shanghai Pharma COVID-19 Medicine Product

Table 134. Shanghai Pharma Revenue in COVID-19 Medicine Business (2019-2024) & (US$ Million)

Table 135. Shanghai Pharma Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Global COVID-19 Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global COVID-19 Medicine Market Share by Type: 2023 VS 2030

Figure 3. Tablet Features

Figure 4. Injection Features

Figure 5. Global COVID-19 Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global COVID-19 Medicine Market Share by Application: 2023 VS 2030

Figure 7. Patients With Mild Symptoms Case Studies

Figure 8. Critically Ill Case Studies

Figure 9. Other Case Studies

Figure 10. COVID-19 Medicine Report Years Considered

Figure 11. Global COVID-19 Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global COVID-19 Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global COVID-19 Medicine Market Share by Region: 2023 VS 2030

Figure 14. Global COVID-19 Medicine Market Share by Players in 2023

Figure 15. Global Top COVID-19 Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Medicine as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by COVID-19 Medicine Revenue in 2023

Figure 17. North America COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America COVID-19 Medicine Market Share by Country (2019-2030)

Figure 19. United States COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe COVID-19 Medicine Market Share by Country (2019-2030)

Figure 23. Germany COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific COVID-19 Medicine Market Share by Region (2019-2030)

Figure 31. China COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America COVID-19 Medicine Market Share by Country (2019-2030)

Figure 39. Mexico COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa COVID-19 Medicine Market Share by Country (2019-2030)

Figure 43. Turkey COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia COVID-19 Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Advanz Pharma Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 46. Kyung Poong Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 47. Mylan Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 48. Novartis Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 49. Sanofi Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 50. Apotex Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 51. Bayer Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 52. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 53. Ipca Laboratories Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 54. Sichuan Sunny Hope Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 55. Zydus Cadila Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 56. Teva Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 57. Sun Pharma Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 58. Rising Pharmaceutical Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 59. KPC Group Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 60. Bristol Laboratories Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 61. Shanghai Zhongxisanwei Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 62. Shanghai Pharma Revenue Growth Rate in COVID-19 Medicine Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oral COVID 19 Drug Market Research Report 2025

Covid 19 Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Drug API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Antiviral Medicines for COVID 19 Market Research Report 2024

Covid 19 Diagnostic Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Approved COVID 19 Vaccines Market Research Report 2025

Oral COVID 19 Antiviral Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Specific Antiviral Drugs for COVID 19 Market

COVID 19 Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vials for COVID 19 Vaccine Market Research Report 2024

COVID 19 In Vitro Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Rapid Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Remdesivir COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Guidewire Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions